We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Cayman Ptupb, 5mg
Product Description
PTUPB is a dual inhibitor of soluble epoxide hydrolase (sEH) and COX-2 (IC50s = 0.009 and 1.26 µM, respectively).1 It is selective for sEH and COX-2 over COX-1 (IC50 = >100 µM). PTUPB (10 mg/kg) increases latency to paw withdrawal in the von Frey mechanical assay in a rat model of LPS-induced inflammatory pain. It inhibits VEGF-induced angiogenesis in a Matrigel™ plug assay in mice, as well as reduces the number of metastases in a murine Lewis lung carcinoma model, when administered at a dose of 30 mg/kg per day.2 PTUPB reduces body and hepatic weights, as well as hepatic triglyceride and cholesterol levels and collagen deposition in a mouse model of high-fat diet-induced non-alcoholic fatty liver disease (NAFLD).3
WARNING This product is not for human or veterinary use.
Technical Information
- DMF: 30 mg/ml
- DMSO: 30 mg/ml
- DMSO:PBS (pH 7.2) (1:2): 0.30 mg/ml
- Ethanol: 1 mg/ml
Shipping & Storage Information
| SKU | CAYM-10897-5 |
|---|---|
| Featured | No |
| Supplier Part Number | 10897-5 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| MSDS URL | Click here |
| Temperature | -20 |
| Refrigerated-Frozen | Refrigerated |
| CountryOfOrigin | China |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 2 |
| Hazardous | N |
| CAS Number | 1287761-01-6 |
| Energy Star | No |
| Green | No |
| ACT Ecolabel | No |
| Controlled | N |